Stephen G. Walsh

Array ( [id] => 3565564 [patent_doc_number] => 05482924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-09 [patent_title] => 'Proteinaceous compositions having an activity on erythropoiesis' [patent_app_type] => 1 [patent_app_number] => 7/987604 [patent_app_country] => US [patent_app_date] => 1992-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4021 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/482/05482924.pdf [firstpage_image] =>[orig_patent_app_number] => 987604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3070561 [patent_doc_number] => 05360728 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-01 [patent_title] => 'Modified apoaequorin having increased bioluminescent activity' [patent_app_type] => 1 [patent_app_number] => 7/982650 [patent_app_country] => US [patent_app_date] => 1992-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12674 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/360/05360728.pdf [firstpage_image] =>[orig_patent_app_number] => 982650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3424015 [patent_doc_number] => 05422250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-06 [patent_title] => 'Process for the preparation of human factor VIII and analogs of factor VIII' [patent_app_type] => 1 [patent_app_number] => 7/970951 [patent_app_country] => US [patent_app_date] => 1992-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6794 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/422/05422250.pdf [firstpage_image] =>[orig_patent_app_number] => 970951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3009801 [patent_doc_number] => 05331094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-19 [patent_title] => 'Purified active somatostatin receptor' [patent_app_type] => 1 [patent_app_number] => 7/963246 [patent_app_country] => US [patent_app_date] => 1992-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10251 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/331/05331094.pdf [firstpage_image] =>[orig_patent_app_number] => 963246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3422628 [patent_doc_number] => 05389612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-14 [patent_title] => 'Phosphonic peptide inhibitors of bacterial collagenases' [patent_app_type] => 1 [patent_app_number] => 7/949760 [patent_app_country] => US [patent_app_date] => 1992-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7324 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/389/05389612.pdf [firstpage_image] =>[orig_patent_app_number] => 949760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3409549 [patent_doc_number] => 05443825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Human leukemia inhibitory factor' [patent_app_type] => 1 [patent_app_number] => 7/948614 [patent_app_country] => US [patent_app_date] => 1992-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 44 [patent_no_of_words] => 19524 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443825.pdf [firstpage_image] =>[orig_patent_app_number] => 948614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3475132 [patent_doc_number] => 05428013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide' [patent_app_type] => 1 [patent_app_number] => 7/947277 [patent_app_country] => US [patent_app_date] => 1992-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3237 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 799 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/428/05428013.pdf [firstpage_image] =>[orig_patent_app_number] => 947277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458401 [patent_doc_number] => 05441869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-15 [patent_title] => 'Method for the determination of fibrin' [patent_app_type] => 1 [patent_app_number] => 7/944691 [patent_app_country] => US [patent_app_date] => 1992-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6461 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/441/05441869.pdf [firstpage_image] =>[orig_patent_app_number] => 944691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3441429 [patent_doc_number] => 05466589 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-14 [patent_title] => 'Coated substrates employing oriented layers of mutant heme proteins and methods of making and using same' [patent_app_type] => 1 [patent_app_number] => 7/945291 [patent_app_country] => US [patent_app_date] => 1992-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 12311 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/466/05466589.pdf [firstpage_image] =>[orig_patent_app_number] => 945291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3482691 [patent_doc_number] => 05405940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-11 [patent_title] => 'Isolated nonapeptides derived from MAGE genes and uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/938334 [patent_app_country] => US [patent_app_date] => 1992-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4903 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/405/05405940.pdf [firstpage_image] =>[orig_patent_app_number] => 938334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3094757 [patent_doc_number] => 05318896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-07 [patent_title] => 'Recombinant expandase bioprocess for preparing 7-aminodesacetoxy cephalosporanic acid (7-ADCA)' [patent_app_type] => 1 [patent_app_number] => 7/933469 [patent_app_country] => US [patent_app_date] => 1992-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13275 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/318/05318896.pdf [firstpage_image] =>[orig_patent_app_number] => 933469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3480118 [patent_doc_number] => 05457042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-10 [patent_title] => 'Sod polypeptide analogs' [patent_app_type] => 1 [patent_app_number] => 7/933682 [patent_app_country] => US [patent_app_date] => 1992-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 25885 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/457/05457042.pdf [firstpage_image] =>[orig_patent_app_number] => 933682 [rel_patent_id] =>[rel_patent_doc_number] =>)